Powering the Immune System to Transform Lives
Vir Biotechnology (vir.bio) scores 77 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 53rd percentile of 9623 Healthcare brands.
Vir Biotechnology is a biotechnology company focused on leveraging the immune system to develop therapies for infectious diseases and cancer. It utilizes a next-generation antibody platform combined with proprietary PRO-XTEN protease-releasable masking technology to identify, optimize, and advance therapeutic candidates. The company targets patients with serious infectious diseases and cancer, as well as healthcare providers, researchers, and biopharmaceutical partners seeking innovative immunologic solutions.
| Brand Name | Vir Biotechnology |
|---|---|
| Domain | vir.bio |
| Industry | Healthcare |
| Main Competitors | Regeneron Pharmaceuticals (92/100), CytomX Therapeutics, Moderna (94/100), Gilead Sciences (81/100), Amgen (90/100), AbCellera Biologics (76/100) |
Moz Domain Authority 49/100 vs category average 41 / leader 97 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #912,674 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
Vir Biotechnology appears on Wikipedia but without a dedicated company entity, so AI models can confuse it with similarly named subjects.
The homepage meta description reads "Vir is leveraging immunologic breakthroughs to address unmet patient needs in infectious disease and beyond." (Meta description: 15 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:image, og:type, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Apache.
Social footprint: verified profiles on LinkedIn, X (Twitter), Facebook, Instagram, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Vir Biotechnology?", Claude could identify the brand as of September 2026. Vir Biotechnology is a clinical-stage immunology company focused on developing therapies for infectious diseases and cancer by harnessing the immune system, using platforms like monoclonal antibodies, T cell engagers, and gene editing. Best known for Developing sotrovimab, a monoclonal antibody used to treat COVID-19 during the pandemic.
When asked "Best brands similar to Vir Biotechnology?", Claude would recommend Vir Biotechnology as of September 2026. It's a notable biotech in infectious disease and immunology, especially recognized for its COVID-19 antibody work and ongoing hepatitis B and cancer programs.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Vir Biotechnology's main competitors in Healthcare: Regeneron Pharmaceuticals (92/100), Moderna (94/100), Gilead Sciences (81/100), Amgen (90/100), AbCellera Biologics (76/100).
Sources: Brand Analyzer scan
Vir Biotechnology has limited AI-search visibility, scoring 35/100 on Brand Analyzer's AI visibility composite (visibility 40, trust 29, recommendation 32). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Vir Biotechnology official site
Vir Biotechnology scores 32/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Vir Biotechnology official site
Vir Biotechnology is a biotechnology company that develops immunologic therapies for infectious diseases and cancer, using antibody-based platforms and proprietary technologies to create novel treatments.
Sources: Vir Biotechnology official site
Vir Biotechnology researches and develops therapeutic candidates that harness the immune system, employing a next-generation antibody platform together with its proprietary PRO-XTEN protease-releasable masking technology to identify, optimize, and advance treatments for infectious diseases and cancer.
Sources: Vir Biotechnology official site
Vir Biotechnology can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Vir Biotechnology official site
Vir Biotechnology is known for its immunology-driven approach to drug development, particularly its use of antibody engineering and the PRO-XTEN masking technology aimed at creating targeted therapies for infectious disease and cancer.
Sources: Vir Biotechnology official site
Vir Biotechnology's work primarily serves patients with serious infectious diseases and cancer, as well as healthcare providers, researchers, and biopharmaceutical partners who collaborate on or utilize its immunologic therapies.
Sources: Vir Biotechnology official site
Vir Biotechnology scores 35/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Vir Biotechnology has a weak AI-visibility profile at 35/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (40/100) and its weakest is trust (29/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #912,674 (Tranco) and a Moz Domain Authority of 49/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Vir Biotechnology from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Vir Biotechnology: VillageMD (77/100), Vetoquinol (77/100), Virtuagym (77/100), Elligint Health (77/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.